Envestnet Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $571K | Sell |
5,770
-2,151
| -27% | -$194K | ﹤0.01% | 3982 |
|
|
2026
Q1 | $687K | Buy |
7,921
+1,316
| +20% | +$115K | ﹤0.01% | 3707 |
|
|
2025
Q4 | $560K | Sell |
6,605
-1,364
| -17% | -$109K | ﹤0.01% | 3625 |
|
|
2025
Q3 | $578K | Sell |
7,969
-664
| -8% | -$45.8K | ﹤0.01% | 3657 |
|
|
2025
Q2 | $566K | Buy |
8,633
+238
| +3% | +$15.5K | ﹤0.01% | 3610 |
|
|
2025
Q1 | $592K | Sell |
8,395
-2,429
| -22% | -$169K | ﹤0.01% | 3521 |
|
|
2024
Q4 | $711K | Sell |
10,824
-2,606
| -19% | -$179K | ﹤0.01% | 3373 |
|
|
2024
Q3 | $948K | Sell |
13,430
-1,063
| -7% | -$74.1K | ﹤0.01% | 3163 |
|
|
2024
Q2 | $961K | Buy |
14,493
+435
| +3% | +$28.5K | ﹤0.01% | 3065 |
|
|
2024
Q1 | $954K | Sell |
14,058
-172,701
| -92% | -$11.4M | ﹤0.01% | 3062 |
|
|
2023
Q4 | $11.5M | Sell |
186,759
-5,334
| -3% | -$313K | ﹤0.01% | 1347 |
|
|
2023
Q3 | $11.3M | Buy |
192,093
+110,514
| +135% | +$6.78M | 0.01% | 1289 |
|
|
2023
Q2 | $4.87M | Sell |
81,579
-2,424
| -3% | -$144K | ﹤0.01% | 1721 |
|
|
2023
Q1 | $4.91M | Buy |
84,003
+65,124
| +345% | +$3.92M | ﹤0.01% | 1667 |
|
|
2022
Q4 | $1.17M | Buy |
18,879
+573
| +3% | +$34.5K | ﹤0.01% | 2517 |
|
|
2022
Q3 | $1.03M | Sell |
18,306
-3,048
| -14% | -$188K | ﹤0.01% | 2542 |
|
|
2022
Q2 | $1.36M | Sell |
21,354
-17,964
| -46% | -$1.14M | ﹤0.01% | 2362 |
|
|
2022
Q1 | $2.55M | Buy |
39,318
+8,664
| +28% | +$549K | ﹤0.01% | 2061 |
|
|
2021
Q4 | $2.04M | Buy |
30,654
+3,777
| +14% | +$240K | ﹤0.01% | 2160 |
|
|
2021
Q3 | $1.64M | Buy |
26,877
+156
| +0.6% | +$9.92K | ﹤0.01% | 2222 |
|
|
2021
Q2 | $1.66M | Sell |
26,721
-3,192
| -11% | -$194K | ﹤0.01% | 2184 |
|
|
2021
Q1 | $1.77M | Sell |
29,913
-219
| -0.7% | -$13.2K | ﹤0.01% | 2022 |
|
|
2020
Q4 | $1.8M | Buy |
30,132
+3,255
| +12% | +$186K | ﹤0.01% | 1818 |
|
|
2020
Q3 | $1.47M | Sell |
26,877
-60
| -0.2% | -$3.24K | ﹤0.01% | 1794 |
|
|
2020
Q2 | $1.38M | Sell |
26,937
-753
| -3% | -$37.9K | ﹤0.01% | 1778 |
|
|
2020
Q1 | $1.24M | Buy |
27,690
+5,490
| +25% | +$277K | ﹤0.01% | 1693 |
|
|
2019
Q4 | $1.19M | Buy |
22,200
+657
| +3% | +$32.4K | ﹤0.01% | 1916 |
|
|
2019
Q3 | $1M | Buy |
21,543
+1,392
| +7% | +$66.7K | ﹤0.01% | 1939 |
|
|
2019
Q2 | $1.01M | Buy |
20,151
+1,257
| +7% | +$62.1K | ﹤0.01% | 1939 |
|
|
2019
Q1 | $970K | Sell |
18,894
-22,230
| -54% | -$1.11M | ﹤0.01% | 1925 |
|
|
2018
Q4 | $1.93M | Buy |
41,124
+19,407
| +89% | +$995K | ﹤0.01% | 1366 |
|
|
2018
Q3 | $1.22M | Sell |
21,717
-7,815
| -26% | -$427K | ﹤0.01% | 695 |
|
|
2018
Q2 | $1.49M | Sell |
29,532
-504
| -2% | -$25K | ﹤0.01% | 908 |
|
|
2018
Q1 | $1.45M | Sell |
30,036
-420
| -1% | -$21.6K | ﹤0.01% | 820 |
|
|
2017
Q4 | $1.57M | Sell |
30,456
-660
| -2% | -$33.9K | ﹤0.01% | 1038 |
|
|
2017
Q3 | $1.62M | Buy |
31,116
+132
| +0.4% | +$6.78K | ﹤0.01% | 990 |
|
|
2017
Q2 | $1.6M | Sell |
30,984
-270
| -0.9% | -$13.6K | ﹤0.01% | 1012 |
|
|
2017
Q1 | $1.57M | Sell |
31,254
-216
| -0.7% | -$10.7K | 0.01% | 1038 |
|
|
2016
Q4 | $1.49M | Buy |
31,470
+1,458
| +5% | +$69.2K | 0.01% | 1042 |
|
|
2016
Q3 | $1.5M | Sell |
30,012
-2,127
| -7% | -$108K | 0.01% | 1070 |
|
|
2016
Q2 | $1.55M | Buy |
32,139
+12,591
| +64% | +$599K | 0.01% | 1128 |
|
|
2016
Q1 | $893K | Sell |
19,548
-90
| -0.5% | -$4.21K | ﹤0.01% | 1372 |
|
|
2015
Q4 | $1.06M | Sell |
19,638
-64,803
| -77% | -$3.41M | ﹤0.01% | 1256 |
|
|
2015
Q3 | $4.17M | Buy |
84,441
+9,549
| +13% | +$547K | 0.02% | 631 |
|
|
2015
Q2 | $4.36M | Buy |
74,892
+19,668
| +36% | +$1.15M | 0.02% | 659 |
|
|
2015
Q1 | $3.17M | Buy |
55,224
+46,314
| +520% | +$2.53M | 0.02% | 761 |
|
|
2014
Q4 | $450K | Buy |
8,910
+8,649
| +3,314% | +$421K | ﹤0.01% | 736 |
|
|
2014
Q3 | $12K | Sell |
261
-3,204
| -92% | -$145K | ﹤0.01% | 2052 |
|
|
2014
Q2 | $156K | Buy |
3,465
+612
| +21% | +$26.3K | ﹤0.01% | 1083 |
|
|
2014
Q1 | $120K | Buy |
2,853
+2,556
| +861% | +$107K | ﹤0.01% | 1088 |
|
|
2013
Q4 | $12K | Sell |
297
-42
| -12% | -$1.58K | ﹤0.01% | 1672 |
|
|
2013
Q3 | $12K | Buy |
339
+189
| +126% | +$6.66K | ﹤0.01% | 1641 |
|
|
2013
Q2 | $5K | Buy |
+150
| New | +$4.98K | ﹤0.01% | 1880 |
|
Other funds holding IHE
IWS
Envestnet Asset Management's IHE Position: Q2 2026 in Review
Envestnet Asset Management reduced its iShares US Pharmaceuticals ETF (IHE) stake by 27% in Q2 2026, selling an estimated $194K and leaving 5,770 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #3982.
Envestnet Asset Management first reported a position in IHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.5M in Q4 2023. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- Envestnet Asset Management held 5,770 shares of iShares US Pharmaceuticals ETF worth $571K as of Q2 2026.
- Envestnet Asset Management sold 2,151 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $194K.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3982 holding.
- Envestnet Asset Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 53 quarters since.
- Envestnet Asset Management's iShares US Pharmaceuticals ETF position peaked at $11.5M in Q4 2023.
- 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.